10.1200/JCO.23.02745 40 Gratacos-GinesJ.ArinoS.Sancho-BruP.BatallerR.PoseE
If you have medullary thyroid cancer or genetic testing that puts you at risk for thyroid cancer, or you have a family member who has medullary thyroid cancer, they say you shouldn't use these drugs
Patients treated with GLP-1 RAs should therefore understand they will need to continue using them long-term
According to Belle Health safety information, these medications are contraindicated for individuals with: Personal or family history of medullary thyroid carcinoma Multiple endocrine neoplasia syndrome type 2 (MEN2) History of pancreatitis Known hypersensitivity to tirzepatide or any of its components Additionally, women who are pregnant, planning to become pregnant, or breastfeeding should not use tirzepatide
doi: 10.3389/fnut.2022.1007816 Received 31 July 2022 Accepted 12 October 2022 Published 01 November 2022 Volume 9 - 2022 Edited by Yannan Jin, De Montfort University, United Kingdom Reviewed by Mostafa Waly, Sultan Qaboos University, Oman
Gastrointestinal Cytoprotection In its original gastric biology context, BPC-157 promotes mucosal integrity through prostaglandin-independent mechanisms, modulates enteric neuron and glial cell activity, counteracts NSAID-induced intestinal permeability, and demonstrates organoprotective activity across the alimentary canal from oesophagus to colon in a range of injury models including ethanol, aspirin, and restraint stress-induced lesions
